Stoessl, A J <br/><br/>
(+)-4-Propyl-9-hydroxynaphthoxazine (PHNO), a new dopaminomimetic, in treatment of parkinsonism.  [electronic resource] 

 -  Lancet (London, England)  Dec 1985 
 - 1330-1 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0140-6736 
<br/><br/><label>Standard No.: </label>10.1016/s0140-6736(85)92627-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Clinical Trials as Topic<br/>Dopamine--physiology<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Oxazines--adverse effects<br/>Parkinson Disease--drug therapy<br/>Time Factors